Join Growin Stock Community!

Prenetics global limitedPRE.US Overview

US StockHealthcare
(No presentation for PRE)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

PRE AI Insights

PRE Overall Performance

PRE AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

PRE Recent Performance

-1.86%

Prenetics global limited

0.05%

Avg of Sector

-0.31%

S&P500

PRE PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

PRE Key Information

PRE Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

PRE Profile

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Price of PRE

PRE FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

PRE Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-4.15
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
3.08
PB Ratio
1.85
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
52.98%
Net Margin
-63.13%
Revenue Growth (YoY)
201.72%
Profit Growth (YoY)
217.82%
3-Year Revenue Growth
-11.26%
3-Year Profit Growth
-6.97%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-4.15
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
3.08
PB Ratio
1.85
Price-to-FCF
-
Gross Margin
52.98%
Net Margin
-63.13%
Revenue Growth (YoY)
201.72%
Profit Growth (YoY)
217.82%
3-Year Revenue Growth
-11.26%
3-Year Profit Growth
-6.97%
  • When is PRE's latest earnings report released?

    The most recent financial report for Prenetics global limited (PRE) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating PRE's short-term business performance and financial health. For the latest updates on PRE's earnings releases, visit this page regularly.

  • What is the operating profit of PRE?

    According to the latest financial report, Prenetics global limited (PRE) reported an Operating Profit of -20.36M with an Operating Margin of -55.69% this period, representing a decline of 22.88% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is PRE's revenue growth?

    In the latest financial report, Prenetics global limited (PRE) announced revenue of 36.56M, with a Year-Over-Year growth rate of 248.57%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does PRE have?

    As of the end of the reporting period, Prenetics global limited (PRE) had total debt of 1.77M, with a debt ratio of 0.01. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does PRE have?

    At the end of the period, Prenetics global limited (PRE) held Total Cash and Cash Equivalents of 32.13M, accounting for 0.16 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does PRE go with three margins increasing?

    In the latest report, Prenetics global limited (PRE) did not achieve the “three margins increasing” benchmark, with a gross margin of 59.5%%, operating margin of -55.69%%, and net margin of -76.9%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess PRE's profit trajectory and future growth potential.

  • Is PRE's EPS continuing to grow?

    According to the past four quarterly reports, Prenetics global limited (PRE)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -1.89. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What are the PEG ratio and PE ratio of PRE?

    The latest valuation data shows Prenetics global limited (PRE) has a Price-To-Earnings (PE) ratio of -5.52 and a Price/Earnings-To-Growth (PEG) ratio of -0.01. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.